The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma

Cytochrome P2C (CYP2C) subfamily members (CYP2C8,CYP2C9,CYP2C18, and CYP2C19) are known to participate in clinical drug metabolism. However, the association between CYP2C subfamily members and hepatocellular carcinoma (HCC) remains unclear. This study investigated the prognostic value of CYP2C subfa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiangkun, Yu, Tingdong, Liao, Xiwen, Yang, Chengkun, Han, Chuangye, Zhu, Guangzhi, Huang, Ketuan, Yu, Long, Qin, Wei, Su, Hao, Liu, Xiaoguang, Peng, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911570/
https://www.ncbi.nlm.nih.gov/pubmed/29479826
http://dx.doi.org/10.1002/cam4.1299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5911570/
https://www.ncbi.nlm.nih.gov/pubmed/29479826
http://dx.doi.org/10.1002/cam4.1299

Ejemplares similares